What is an FDA Form 483?

A Form FDA 483 lists an FDA investigator’s written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.

Does this Form 483 mean Kibun Foods Inc. Funabasi Factory violated the law?

No. A Form 483 documents an investigator's observations only. FDA reviews the firm's written response and any corrective actions taken before deciding whether further action is warranted, and many 483s are closed without additional enforcement once a firm shows adequate correction.

What happens after a Form 483 is issued?

The firm typically has 15 business days to submit a written response describing planned corrections. FDA reviews that response, and unresolved or serious findings can lead to a Warning Letter, import alert, or other enforcement action, though many 483s are resolved without further FDA action.

Has Kibun Foods Inc. Funabasi Factory had other FDA inspection citations?

This is the only FDA action Argus HQ has on file for Kibun Foods Inc. Funabasi Factory so far. Argus ingests new FDA records daily.

FDA Inspects Kibun Foods Inc. Funabasi Factory: Form 483 with 1 Citations (March 13, 2026)

Key facts

Firm	Kibun Foods Inc. Funabasi Factory
FEI / inspection ID	3004323569
Inspection end date	March 13, 2026
Citation count	1

Key takeaway: FDA inspected Kibun Foods Inc. Funabasi Factory in Japan and issued a Form 483 listing 1 inspectional observation following an inspection that concluded 2026-03-13. FDA records classify Kibun Foods Inc. Funabasi Factory as a shell egg producer. A Form 483 documents an investigator's findings at the close of an inspection under the Federal Food, Drug, and Cosmetic Act; it is not a final agency compliance determination. The observations on this page are drawn directly from the FDA-issued Form 483 record.

Citations explained

Observation 1 — -- 1 of 2 -- -- 2 of 2

-- 1 of 2 -- -- 2 of 2 -- A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it. A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.

What a Form 483 means

A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.

Kibun Foods Inc. Funabasi Factory’s FDA history

Argus HQ has recorded 1 total FDA action tied to Kibun Foods Inc. Funabasi Factory: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

Frequently asked questions

What is an FDA Form 483?: A Form FDA 483 lists an FDA investigator’s written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.
Does this Form 483 mean Kibun Foods Inc. Funabasi Factory violated the law?: No. A Form 483 documents an investigator's observations only. FDA reviews the firm's written response and any corrective actions taken before deciding whether further action is warranted, and many 483s are closed without additional enforcement once a firm shows adequate correction.
What happens after a Form 483 is issued?: The firm typically has 15 business days to submit a written response describing planned corrections. FDA reviews that response, and unresolved or serious findings can lead to a Warning Letter, import alert, or other enforcement action, though many 483s are resolved without further FDA action.
Has Kibun Foods Inc. Funabasi Factory had other FDA inspection citations?: This is the only FDA action Argus HQ has on file for Kibun Foods Inc. Funabasi Factory so far. Argus ingests new FDA records daily.

See if this 483 escalates to a warning letter — before your auditor asks.

Free weekly briefing tracks every FDA inspection outcome.

Full FDA history for Kibun Foods Inc. Funabasi Factory

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). FDA Inspects Kibun Foods Inc. Funabasi Factory: Form 483 with 1 Citations (March 13, 2026). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/483/kibun-foods-funabasi-factory-3004323569-2026-03-13

MLA

"FDA Inspects Kibun Foods Inc. Funabasi Factory: Form 483 with 1 Citations (March 13, 2026)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/483/kibun-foods-funabasi-factory-3004323569-2026-03-13.

Chicago

Argus HQ Research. "FDA Inspects Kibun Foods Inc. Funabasi Factory: Form 483 with 1 Citations (March 13, 2026)." Digital Empire Holdings LLC. Accessed August 17, 2026. https://argushq.ai/483/kibun-foods-funabasi-factory-3004323569-2026-03-13.

BibTeX

@misc{argushq_argushq_ai_483_kibun_foods_funabasi_factory_3004323569_2026_03_13_2026,
  title = {FDA Inspects Kibun Foods Inc. Funabasi Factory: Form 483 with 1 Citations (March 13, 2026)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/483/kibun-foods-funabasi-factory-3004323569-2026-03-13},
  note = {Accessed: August 17, 2026}
}

Source: FDA.gov — Inspection Classification Database ↗